Discontinued — last reported Q3 '23
Current Assets
Derivative assets
Pfizer Derivative assets decreased by 17.5% to $1.58B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.6%, from $1.51B to $1.58B. Over 4 years (FY 2020 to FY 2024), Derivative assets shows an upward trend with a 42.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2017
Last reportedQ3 2023
How to read this metric
Fluctuations reflect changes in market conditions and the firm's overall derivative hedging or trading strategy.
Detailed definition
This represents the fair value of derivative contracts that are in a gain position for the firm. These instruments are u...
Peer comparison
Standard for large financial institutions with significant capital markets operations.
Metric ID:
fin_derivative_assetsHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $959.00M | $823.00M | $968.00M | $930.00M | $1.29B | $1.78B | $1.08B | $1.49B | $1.61B | $1.47B | $700.00M | $1.15B | $1.23B | $1.51B | $1.52B | $1.31B | $1.91B | $1.58B |
| QoQ Change | — | -14.2% | +17.6% | -3.9% | +38.8% | +37.6% | -39.3% | +38.0% | +7.9% | -8.6% | -52.3% | +63.7% | +7.2% | +22.8% | +0.5% | -13.3% | +45.4% | -17.5% |
| YoY Change | — | — | — | — | +34.6% | +115.9% | +11.4% | +60.0% | +24.4% | -17.4% | -35.1% | -23.0% | -23.5% | +2.7% | +116.6% | +14.7% | +55.6% | +4.6% |
Range$700.00M – $1.91B
CAGR+12.4%
Avg YoY Growth+24.4%
Median YoY Growth+13.0%
Derivative assets at Other Companies
Frequently Asked Questions
- What is Pfizer's derivative assets?
- Pfizer (PFE) reported derivative assets of $1.58B in Q3 2025.
- How has Pfizer's derivative assets changed year-over-year?
- Pfizer's derivative assets increased by 4.6% year-over-year, from $1.51B to $1.58B.
- What is the long-term trend for Pfizer's derivative assets?
- Over 4 years (2020 to 2024), Pfizer's derivative assets has grown at a 42.0% compound annual growth rate (CAGR), from $373.00M to $1.52B.
- What does derivative assets mean?
- The value of derivative contracts that currently have a positive market value for the firm.